Cartesian Therapeutics, Inc.·4

Jan 4, 5:04 PM ET

Kalayoglu Murat 4

4 · Cartesian Therapeutics, Inc. · Filed Jan 4, 2024

Insider Transaction Report

Form 4
Period: 2024-01-02
Transactions
  • Award

    Common Stock

    [F1]
    2024-01-02+178,000435,739 total
  • Award

    Stock Option (Right to Buy)

    [F3]
    2024-01-02+228,000228,000 total
    Exercise: $0.66Exp: 2034-01-01Common Stock (228,000 underlying)
Holdings
  • Common Stock

    [F2]
    (indirect: By Trust)
    3,303,699
Footnotes (3)
  • [F1]Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in three equal annual installments so that the underlying shares will be fully vested on January 2, 2027.
  • [F2]Shares are held in a trust (the "Trust") for the benefit of the reporting person's spouse and children. The reporting person's spouse is a trustee of the trust.
  • [F3]This award will vest in 36 equal monthly installments, so that it shall be fully vested on January 2, 2027.
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Murat Kalayoglu|2024-01-02

Documents

5 files
  • 4
    wk-form4_1704405827.xmlPrimary

    FORM 4

  • EX-24.1
  • GRAPHIC
    poakalayoglu001.jpg

    GRAPHIC

  • GRAPHIC
    poakalayoglu002.jpg
  • GRAPHIC
    poakalayoglu003.jpg